Drugs / AB-free kava

Trials 2

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT07219186 Apr 2026 → Mar 2027 expected sleep disorder University of Florida Not yet recruiting No outcome recorded
Phase 21 trial
Phase 2 NCT05814055 Jun 2024 → Jan 2027 expected — University of Florida Recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as AB-free kava ClinicalTrials.gov intervention name — accepted as the source's own label NCT05814055 ↗
1

NCT07219186 ↗

Modality Traditional medicine (herbal / TCM) “a traditional plant-based supplement” NCT07219186 ↗
Route Oral “Participants on this arm will take one kava capsule (each capsule contains 75 mg of kavalactones) orally three times daily for 4 weeks.” NCT05814055 ↗